Skip to content

Pulmonx Corporation LUNG Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$88.55M-2.2%$90.5M-1.3%$91.66M+1.2%$90.55M+3.5%$87.47M+4.4%
$21.7M-7.1%$23.36M-4.6%$24.48M+0.4%$24.39M+5.1%$23.21M+6.5%
$66.84M-0.4%$67.14M-0.1%$67.19M+1.6%$66.16M+3.0%$64.27M+3.7%
75.5%+1.3pp74.2%+0.9pp73.3%+0.2pp73.1%-0.4pp73.5%-0.5pp
$19.63M+0.7%$19.49M+3.1%$18.91M+6.2%$17.81M-1.7%$18.12M+3.1%
$99.26M-2.0%$101.31M-3.9%$105.46M+0.2%$105.27M+1.3%$103.88M+1.7%
$118.9M-1.6%$120.8M-2.9%$124.37M+1.0%$123.08M+0.9%$122M+1.9%
-$52.06M+3.0%-$53.66M+6.1%-$57.18M-0.5%-$56.91M+1.4%-$57.73M0.0%
-58.8%+0.5pp-59.3%+3.1pp-62.4%+0.5pp-62.9%+3.1pp-66%+2.9pp
$3.35M+6.2%$3.16M-2.2%$3.23M-2.6%$3.31M-2.7%$3.41M-2.9%
$719K-11.1%$809K-8.7%$886K+1,314%-$73K-1,013%$8K-96.9%
-$52.57M+1.5%-$53.38M+5.1%-$56.28M+0.2%-$56.4M+0.4%-$56.64M-1.3%
$640K+2.2%$626K+31.0%$478K-11.8%$542K+20.7%$449K-10.2%
-$53.21M+1.5%-$54M+4.8%-$56.75M+0.3%-$56.94M+0.3%-$57.09M-1.2%
-60.1%-0.4pp-59.7%+2.2pp-61.9%+1.0pp-62.9%+2.4pp-65.3%+2.0pp
-$1.30+2.3%-$1.33+5.7%-$1.41+1.4%-$1.43+0.7%-$1.440.0%
-$51.06M+2.9%-$52.61M+6.2%-$56.06M-0.7%-$55.67M+1.3%-$56.38M-0.3%
-57.7%+0.5pp-58.1%+3.0pp-61.2%+0.3pp-61.5%+3.0pp-64.5%+2.6pp
-$52.06M+3.0%-$53.66M+6.1%-$57.18M-0.5%-$56.91M+1.4%-$57.73M0.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Pulmonx Corporation's revenue?
Pulmonx Corporation (LUNG) generated $88.5M in revenue over the trailing twelve months, up 1.2% year over year.
Is Pulmonx Corporation profitable?
Pulmonx Corporation is not currently profitable: it reported a net loss of $53.2M over the trailing twelve months, a -60.1% net margin.
What are Pulmonx Corporation's profit margins?
Gross margin is 75.5% and operating margin is -58.8%, with a -60.1% net margin.
What is Pulmonx Corporation's earnings per share?
Pulmonx Corporation's diluted EPS over the trailing twelve months is $-1.30.
Where does Pulmonx Corporation's income statement data come from?
Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.